As elevated FAK expression in breast cancer is associated with a triple-negative cell phenotype [49], our results support a model whereby FAK activity-mediated modulation of NS levels may be part of a mesenchymal- or stem cell-associated regulatory circuit. This evidence concerns the gene PTK2 and breast carcinoma.